269 related articles for article (PubMed ID: 32250304)
101. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease.
Rigaud AS; Fagnani F; Bayle C; Latour F; Traykov L; Forette F
J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):140-5. PubMed ID: 12967055
[TBL] [Abstract][Full Text] [Related]
102. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
Kosaner Kließ M; Martins R; Connolly MP
J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
[TBL] [Abstract][Full Text] [Related]
103. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
104. Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
Qureshi ZP; Thiel E; Nelson J; Khandker R
J Alzheimers Dis; 2021; 83(4):1679-1690. PubMed ID: 34420974
[TBL] [Abstract][Full Text] [Related]
105. Alzheimer's disease: the strength of association of costs with different measures of disease severity.
Mauskopf J; Racketa J; Sherrill E
J Nutr Health Aging; 2010 Oct; 14(8):655-63. PubMed ID: 20922342
[TBL] [Abstract][Full Text] [Related]
106. Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
Sušac J; Vukojević J; Debogović S; Bajić Ž; Savić A; Đuran N; Hanževački M; Vitezić D; Mimica N
J Alzheimers Dis; 2023; 94(4):1417-1430. PubMed ID: 37424466
[TBL] [Abstract][Full Text] [Related]
107. Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
Fukuda H; Kanzaki H; Murata F; Maeda M; Ikeda M
J Alzheimers Dis; 2023; 95(4):1559-1572. PubMed ID: 37718811
[TBL] [Abstract][Full Text] [Related]
108. Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Sköldunger A; Jönsson L
Alzheimers Dement; 2019 Oct; 15(10):1309-1321. PubMed ID: 31402324
[TBL] [Abstract][Full Text] [Related]
109. Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System.
Jones E; Aigbogun MS; Pike J; Berry M; Houle CR; Husbands J
J Alzheimers Dis; 2021; 83(1):89-101. PubMed ID: 34250934
[TBL] [Abstract][Full Text] [Related]
110. Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.
Biasutti M; Dufour N; Ferroud C; Dab W; Temime L
PLoS One; 2012; 7(4):e35559. PubMed ID: 22532859
[TBL] [Abstract][Full Text] [Related]
111. Economic Burden of Alzheimer's Disease Dementia in Japan.
Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
[TBL] [Abstract][Full Text] [Related]
112. Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey.
Ohno S; Chen Y; Sakamaki H; Matsumaru N; Yoshino M; Tsukamoto K
J Med Econ; 2021; 24(1):266-278. PubMed ID: 33538195
[TBL] [Abstract][Full Text] [Related]
113. Modelling the Pan-European Economic Burden of Alzheimer's Disease.
Martins R; Urbich M; Brännvall K; Gianinazzi M; Ching JE; Khoury CP; El-Hayek YH
JAR Life; 2022; 11():38-46. PubMed ID: 36923231
[TBL] [Abstract][Full Text] [Related]
114. Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial.
Søgaard R; Sørensen J; Waldorff FB; Eckermann A; Buss DV; Waldemar G
BMC Health Serv Res; 2009 Nov; 9():215. PubMed ID: 19939249
[TBL] [Abstract][Full Text] [Related]
115. Cost of Patients with Alzheimer's Disease in Spain According to Disease Severity.
Gómez Maldonado L; de Mora-Figueroa R; López-Angarita A; Maravilla-Herrera P; Merino M
Pharmacoecon Open; 2024 Jan; 8(1):103-114. PubMed ID: 37966711
[TBL] [Abstract][Full Text] [Related]
116. Healthcare resource utilization and economic burden of multiple sclerosis in Chinese patients: results from a real-world survey.
Sun C; Jia Y; Li H; Qiao X; Tang M; Geng M; Jones E; Pike J; Unsworth M; Hu M
Sci Rep; 2024 Jul; 14(1):15183. PubMed ID: 38956085
[TBL] [Abstract][Full Text] [Related]
117. Patterns of Symptom Tracking by Caregivers and Patients With Dementia and Mild Cognitive Impairment: Cross-sectional Study.
Dunn T; Howlett SE; Stanojevic S; Shehzad A; Stanley J; Rockwood K
J Med Internet Res; 2022 Jan; 24(1):e29219. PubMed ID: 35084341
[TBL] [Abstract][Full Text] [Related]
118. Disease Burdens of Alzheimer's Disease, Vascular Dementia, and Mild Cognitive Impairment.
Moon W; Han JW; Bae JB; Suh SW; Kim TH; Kwak KP; Kim BJ; Kim SG; Kim JL; Moon SW; Park JH; Ryu SH; Youn JC; Lee DY; Lee DW; Lee SB; Lee JJ; Jhoo JH; Kim KW
J Am Med Dir Assoc; 2021 Oct; 22(10):2093-2099.e3. PubMed ID: 34237255
[TBL] [Abstract][Full Text] [Related]
119. The economic and societal burden of Alzheimer disease: managed care considerations.
Skaria AP
Am J Manag Care; 2022 Sep; 28(10 Suppl):S188-S196. PubMed ID: 36197132
[TBL] [Abstract][Full Text] [Related]
120. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment.
Hsiao JJ; Lu PH; Grill JD; Teng E
Dement Geriatr Cogn Disord; 2015; 39(1-2):12-24. PubMed ID: 25300404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
